FSIP2 and esophageal squamous cell carcinoma: Using a combination of a 35-gene mutation profile, clinical nodal staging, and RT dosimetry, mutations in FSIP2 and SYNE1 were identified as potential predictors of outcomes of definitive CCRT in patients with ESCC.